Detalhe da pesquisa
1.
Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors.
Naunyn Schmiedebergs Arch Pharmacol
; 372(5): 354-61, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16489449
2.
Cannabinoid CB(1) receptor-mediated inhibition of hippocampal acetylcholine release is preserved in aged mice.
Br J Pharmacol
; 138(8): 1425-30, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12721097
3.
Lack of CB1 receptors increases noradrenaline release in vas deferens without affecting atrial noradrenaline release or cortical acetylcholine release.
Br J Pharmacol
; 140(2): 323-8, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12970076
4.
Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor.
Naunyn Schmiedebergs Arch Pharmacol
; 385(4): 385-96, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22215206